PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
20.27
Positive P/E while Healthcare median is negative at -0.85. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
2.70
P/S less than half the Healthcare median of 6.07. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
2.72
P/B exceeding 1.5x Healthcare median of 1.76. Jim Chanos would check for potential asset write-down risks.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.72
Fair value ratio exceeding 1.5x Healthcare median of 1.77. Jim Chanos would check for valuation bubble risks.
1.23%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
No Data
No Data available this quarter, please select a different quarter.